Wednesday, February 28, 2018

Financial News Conference
Full Year 2017 results

Location: Leverkusen, Baykomm (Bayer‘s Communication Center)

Bayer: business at prior-year level – on track with strategy

Group sales increased by 1.5 percent (Fx & portfolio adj.) to 35.015 billion euros / Another record year for Pharmaceuticals / Weak business development at Consumer Health / Crop Science business down against prior year due to situation in Brazil – measures taking effect / EBITDA before special items level year on year at 9.288 billion euros / EBITDA before special items level year on year at 9.288 billion euros / Core earnings per share increased by 1.0 percent to 6.74 euros / Covestro deconsolidated – additional cash inflows of 4.7 billion euros / Monsanto acquisition expected to close in second quarter of 2018 / Group outlook for 2018: increase in sales (Fx & portfolio adj.), EBITDA before special items and core earnings per share at prior-year level due to currency effects
more

Links

Statement by Werner Baumann on the FY 2017 results

Speaker

Werner Baumann

Werner Baumann
CEO of Bayer AG

Johannes Dietsch

Johannes Dietsch
CFO of Bayer AG

Follow us:

Twitter

You will find more news from @Bayer on » Twitter